Research Article
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
Table 1
Clinical and pathological data of osteosarcoma patients for global miRNA expression study.
| Case number | Gender | Age | Location | Histologic type | Neoadjuvant chemotherapy | Viable cells |
| Case 1 | Female | 11 | Tibia | Osteoblastic | MTX + DOX + CDDP | 0% | Case 2 | Male | 18 | Tibia | Osteoblastic | MTX + DOX + CDDP | 9% | Case 3 | Male | 15 | Tibia | Osteoblastic | MTX + DOX + CDDP | 0% | Case 4 | Female | 13 | Femur | Osteoblastic | MTX + DOX + CDDP | 0% | Case 5 | Female | 10 | Femur | Osteoblastic | MTX + DOX + CDDP | 70% | Case 6 | Male | 25 | Tibia | Osteoblastic | MTX + DOX + CDDP | 40% | Case 7 | Male | 12 | Femur | Osteoblastic | MTX + DOX + CDDP | 20% | Case 8 | Female | 16 | Femur | Osteoblastic | MTX + DOX + CDDP | 22% |
|
|
A: probability of viable cells was pathologically evaluated by surgical specimen.
|